- Home
- NLSP vs MYNZ Comparison
NLSP vs MYNZ Comparison
Compare NLSP & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- MYNZ
- Stock Information
- Founded
- NLSP 2015
- MYNZ 2021
- Country
- NLSP Switzerland
- MYNZ Germany
- Employees
- NLSP N/A
- MYNZ N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- NLSP Health Care
- MYNZ Health Care
- Exchange
- NLSP Nasdaq
- MYNZ Nasdaq
- Market Cap
- NLSP 243.8M
- MYNZ N/A
- IPO Year
- NLSP 2021
- MYNZ 2021
- Fundamental
- Price
- NLSP $4.96
- MYNZ $0.31
- Analyst Decision
- NLSP
- MYNZ Buy
- Analyst Count
- NLSP 0
- MYNZ 2
- Target Price
- NLSP N/A
- MYNZ $3.00
- AVG Volume (30 Days)
- NLSP 34.6K
- MYNZ 2.3M
- Earning Date
- NLSP 11-01-2024
- MYNZ 11-14-2024
- Dividend Yield
- NLSP N/A
- MYNZ N/A
- EPS Growth
- NLSP N/A
- MYNZ N/A
- EPS
- NLSP N/A
- MYNZ N/A
- Revenue
- NLSP N/A
- MYNZ $917,203.00
- Revenue This Year
- NLSP N/A
- MYNZ $36.69
- Revenue Next Year
- NLSP N/A
- MYNZ $91.67
- P/E Ratio
- NLSP N/A
- MYNZ N/A
- Revenue Growth
- NLSP N/A
- MYNZ 16.23
- 52 Week Low
- NLSP $4.08
- MYNZ $0.19
- 52 Week High
- NLSP $29.68
- MYNZ $3.39
- Technical
- Relative Strength Index (RSI)
- NLSP 46.37
- MYNZ 51.63
- Support Level
- NLSP $4.52
- MYNZ $0.28
- Resistance Level
- NLSP $5.64
- MYNZ $0.33
- Average True Range (ATR)
- NLSP 0.48
- MYNZ 0.05
- MACD
- NLSP 0.07
- MYNZ 0.00
- Stochastic Oscillator
- NLSP 55.44
- MYNZ 42.69
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.